You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD123 Acute Myeloid Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

Recruiting
  • Myelofibrosis
  • +2 more
  • Charlottesville, Virginia
    Danyelle Coley
Jan 18, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 16, 2022

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia Recurrent
  • CD123-CAR-NK cells
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Oct 24, 2022

Acute Myeloid Leukemia Trial in Valencia (AFM28)

Recruiting
  • Acute Myeloid Leukemia
  • Valencia, Spain
    Hospital Universitari i Politècnic La Fe
Apr 5, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Cyclophosphamide (Non-IMP, Lymphodepletion)
  • +3 more
  • Ulm, Baden-Württemberg, Germany
  • +4 more
Jul 24, 2023

Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

Recruiting
  • Acute Myeloid Leukemia
  • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
  • Beijing, Beijing, China
  • +2 more
Aug 8, 2023

Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Sep 5, 2023

Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123

Recruiting
  • Leukemia
  • +3 more
  • MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
  • Amsterdam, Netherlands
  • +4 more
Jan 4, 2023

AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

Recruiting
  • AML
  • +4 more
  • CD123-CAR T
  • +4 more
  • Memphis, Tennessee
  • +1 more
May 10, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia, Refractory Trial in Philadelphia

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • +2 more
  • CART123 cells; cyclophosphamide; fludarabine
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Feb 28, 2022

Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Biospecimen Collection
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia Trial

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • +7 more
  • Anti-CD123 ADC IMGN632
  • +7 more
  • (no location specified)
Dec 28, 2022

Acute Myeloid Leukemia Trial in Italy (tagraxofusp)

Recruiting
  • Acute Myeloid Leukemia
  • Bergamo, Italy
  • +7 more
Dec 17, 2021

Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

Recruiting
  • Recurrent Acute Leukemia
  • +16 more
  • Duarte, California
    City of Hope Medical Center
Nov 22, 2022

Acute Myeloid Leukemia (AML) Trial in Germany (Cyclophosphamide (Non-IMP), Fludarabine (Non-IMP), TM123 (IMP))

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Cyclophosphamide (Non-IMP)
  • +3 more
  • Ulm, Baden-Württemberg, Germany
  • +5 more
Dec 28, 2021

Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • +3 more
  • Gilbert, Arizona
  • +14 more
Apr 20, 2022

Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

Recruiting
  • Leukemia, Acute Myeloid
  • +7 more
  • Denver, Colorado
  • +4 more
Aug 29, 2022

Leukemia, Myeloid, Acute Trial in Spain, United States (JNJ-63709178)

Completed
  • Leukemia, Myeloid, Acute
  • Detroit, Michigan
  • +9 more
Aug 30, 2021

Acute Myelogenous Leukemia, B-cell Acute Lymphoblastic Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor Trial in United

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • XmAb14045
  • Jacksonville, Florida
  • +8 more
Mar 4, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Kunming (CD123 CAR-T cells)

Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force
Mar 1, 2021

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Chongqing (CD123 CAR-T cells)

Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Mar 1, 2021

Acute Myeloid Leukemia Trial in Hangzhou (IL3 CAR T-cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • IL3 CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital，College of Medicine, Zhejiang Univ
Oct 22, 2020